by Robert Neil and Mary Thompson The aging US population is fueling increased demand in a number of health care markets, and nowhere are these changing demographic forces more evident than in the area
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly A look at medical device and in vitro diagnostics/research financing, M&A, and alliance activity July-September 2007 In this
There’s no doubt biomarker diagnostics are the linchpin of personalized medicine. But building a successful business around such tests is anything but straightforward, given the complexities associate
Diseases of the prostate constitute the second most prevalent type of chronic disease in the male population in the US, because they share with heart disease, the number one killer, a preference for m